| 摘要 |
<p>This invention provides compounds of formula (I), wherein X is (CH2)n, O, S, SO, SO2, or CR1R2; n is 1 or 2; R?1 and R2¿ H, halogen, hydroxy, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, or R?1 and R2¿, taken together form cycloakyl of 3 to 6 carbon atoms, an alkylidene of up to 6 carbon atoms or a carbonyl; R?3, R4 and R5¿ are H or alkyl of 1 to 6 carbon atoms; Z is H, alkyl of 1 to 6 carbon atoms, alkynoyl of 1 to 6 carbon atoms or alkoxycarbonyl of 2 to 7 carbon atoms; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions and methods for their use in treating or preventing characterized by glutamate hypofunction, including schizophrenia, schizoaffective disorder and schizophreniform disorder, and for the treatment of cognitive deficits due to aging, stroke, Alzheimer's disease or other neurodegenerative diseases.</p> |
